Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | June 2025 | YoY |
|---|---|---|
| Revenue | 72.48m | - |
| Gross profit | 10.43m | - |
| Net profit | -4.26m | - |
| EBITDA | -2.66m | - |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €109.73m |
Number of shares | 725.33m |
52-week high/low | €0.34 - €0.13 |
| Dividends | No |
Beta | -0.58 |
P/E ratio | -5.63 |
PEG ratio | 0.07 |
P/B ratio | 0.72 |
P/S ratio | 0.40 |
Company profile
Sipai Health Technology Co., Ltd. operates as a medical technology and health management company in the People's Republic of China. The company operates through three segments: Specialty Pharmacy Business, Physician Research Assistance Business, and Health Insurance Services Business. The Specialty Pharmacy Business segment operates specialty pharmacy stores; and distributes pharmaceutical products to pharmaceutical companies and other distributors. The Physician Research Assistance Business segment offers pharmaceutical companies and other clinical trial institutions site management organization services, including site feasibility, site initiation, patient recruitment, patient management, data entry and document management, on-site drug management and bio-sample management, site closure, and others; and services for image management in clinical trials. The Health Insurance Services Business segment provides insurance brokerage services to insurance companies. The company was founded in 2014 and is headquartered in Guangzhou, the People's Republic of China.
| Name | SIPAI HEALTH TECHNOLOGY CO L |
| CEO | Xuguang Ma |
| Headquarters | Shanghai,
sh China |
| Website | |
| IPO | 23/12/2022 |
| Employees | 3,131 |
Deep Dive
Ticker symbols
| Exchange | Symbol |
|---|---|
Frankfurt | AX1.F |
Düsseldorf | AX1.DU |
München | AX1.MU |